abstract |
Peptides for use in inhibiting interactions of PF4 and RANTES are disclosed herein in certain embodiments. Methods for treating an inflammatory disease, disorder, condition, or symptom are disclosed here. In some embodiments, the method comprises co-administering an agent that inhibits the interactions of PF4 and RANTES and a second active agent. |